Western Medicine GMP Fructose Sodium Diphosphate for Injection Ischemia Myocardial

• Application: Surgery
• Suitable for: Adult
• State: Liquid
• Shape: Powder
• Type: Biological Products
• Pharmaceutical Technology: Natural Product Extraction
• Model NO.: 5g
• Transport Package: CTN
• Trademark: UNIPHAR
• Origin: China
• HS Code: 3004909099
• Production Capacity: 500000

Product Description

Fructose Sodium Diphosphate:  


Fructose Diphosphate Sodium For Injection, the product is a white crystalline powder.

For myocardial ischemia, shock, hypoxia, adjuvant treatment of tissue damage.

This product is bottled preparation and injection of two kinds of specifications, 50ml vials containing 5 grams of fructose sodium phosphate injection was two, each 0.5 grams of fructose sodium phosphate on the two. Products are generally well tolerated, can drip pain, rash, numb lips, occasional dizziness, chest tightness and allergic reactions.

Allergic to this product, high blood pressure, renal failure.

Pharmacology and toxicology

 

This product is the intermediate product in glucose metabolism, exogenous fructose two phosphate can act on the cell membrane, the cell membrane through activation of phosphofructokinase, increase the concentration of high-energy phosphate bond and ATP in cells, thereby promoting potassium influx, restore the cell resting state, increase the content of red blood cells - the and the inhibition of oxygen free radicals and histamine release, beneficial to shock, ischemia, hypoxia, tissue injury, cardiopulmonary bypass, the use of cell energy metabolism such as blood transfusion condition and glucose, to promote the repair, improve the cell function.

 

Indications

This product is suitable for low hypophosphoric acid blood phosphate.

 

Dosage

The recommended dose is 5-10g per day, and a larger dose is recommended for two doses per day.

The dose should be based on body weight (70-160mg/kg), not exceeding the recommended dose.